Brown University’s RTFCCR Clinical Research Grants fund innovative, patient-focused Phase I–III cancer clinical trials to advance treatment and quality of life.
CRI Technology Impact Award supports technology developers and clinical cancer immunologists in creating unbuilt, untested technologies to overcome barriers and enable more effective cancer immunotherapies.
CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.
The Decentralized Clinical Trial Initiative (DCTI) supports oncology trial teams conducting technology-informed treatment studies that bring investigational care closer to patients, ideally at home.
Accelerate translational research through innovation across CTSA Program Consortium—funding for new approaches, technologies, resources, and models.